Altamira Therapeutics Ltd. Adjustments For Increase Decrease In Employee Benefit Liabilities
Altamira Therapeutics Ltd. (CYTOF) reported Adjustments For Increase Decrease In Employee Benefit Liabilities of $46.87 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities · last filed 2025-08-29
CHF
| Period end | Adjustments For Increase Decrease In Employee Benefit Liabilities 6 month | Adjustments For Increase Decrease In Employee Benefit Liabilities 12 month |
|---|---|---|
| 2023-12-31 | 41.59K CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | 16.31K CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | 109.16K CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | 56.38K CHF 6-K · filed 2023-09-12 | |
| 2021-12-31 | 65.93K CHF 20-F/A · filed 2024-04-22 | |
| 2021-06-30 | 26.10K CHF 6-K/A · filed 2023-08-21 | |
| 2020-12-31 | 80.81K CHF 20-F · filed 2023-05-16 | |
| 2020-06-30 | 38.32K CHF 6-K · filed 2021-09-08 | |
| 2019-12-31 | 40.15K CHF 20-F · filed 2022-04-12 | |
| 2019-06-30 | 16.03K CHF 6-K/A · filed 2020-09-17 | |
| 2018-12-31 | -37.49K CHF 20-F · filed 2021-03-31 | |
| 2018-06-30 | 113.32K CHF 6-K · filed 2019-08-15 | |
| 2017-12-31 | 142.51K CHF 20-F · filed 2020-04-16 | |
| 2016-12-31 | 122.50K CHF 20-F · filed 2019-03-14 | |
| 2015-12-31 | 111.32K CHF 20-F · filed 2018-03-22 |
USD
| Period end | Adjustments For Increase Decrease In Employee Benefit Liabilities 6 month | Adjustments For Increase Decrease In Employee Benefit Liabilities 12 month |
|---|---|---|
| 2025-06-30 | $46.87K 6-K · filed 2025-08-29 | |
| 2024-12-31 | $61.13K 20-F · filed 2025-04-30 | |
| 2024-06-30 | $29.80K 6-K · filed 2025-08-29 | |
| 2023-12-31 | $46.28K 20-F · filed 2025-04-30 | |
| 2023-06-30 | $17.89K 6-K · filed 2024-09-24 | |
| 2022-12-31 | $114.31K 20-F · filed 2025-04-30 |